10105870Streamlining the Manufacturing for MyoCaidClosedLaunchpadInnovate UKThis project will advance the development of MyoCaid, an innovative new medical device to treat patients with advanced heart failure. Heart failure is the single biggest cause of death, and is responsible for approximately 60,000 deaths per year in the UK alone. Doctors have pills they can give to help patients with heart failure, but when heart failure becomes very severe, these pills are less effective, and sadly, the prognosis is often very poor. Cardiology Devices Limited is developing a new, mechanical treatment to both alleviate the symptoms, and prolong the life of patients with severe heart failure, so they can be treated with a device which helps the heart pump blood. In particular, this device is targetted at older, frailer patients who have had heart attacks who currently are normally not eligible for mechanical devices. Overall, this treatment aims to address the major health condition of heart failure by both alleviating symptoms and prolonging life, as well as address the underlying healthcare inequality which is inherent to the selection of appropriate patients for mechanical devices and heart transplantation. Cardiology Devices hopes that this treatment can become the standard of care for patients with severe heart failure, and we can give patients years or decades more of healthy, symptom free life, without needing a heart transplant, and without the complications of traditional mechanical devices.